ClinicalTrials.Veeva

Menu

Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants (Vakzimeter FLU)

Sanofi logo

Sanofi

Status

Active, not recruiting

Conditions

Influenza Immunization

Study type

Observational

Funder types

Industry

Identifiers

NCT06800885
FLU00216

Details and patient eligibility

About

Real-time monitoring of vaccination rates for Germany is unavailable, and up-to-date data publication is delayed, which makes it challenging to develop effective public health strategies to increase vaccination coverage.

This study aims to address the gap by assessing current influenza vaccination rates, particularly among those aged 60 and older, to inform public health interventions and encourage healthcare providers to recommend influenza vaccination more proactively.

The primary objective of this study is to determine the influenza vaccination rates in the German population during the current respiratory season. The study will focus on:

  1. Assessing the vaccination rates among the two main age groups 18 years of age through and including 59 years of age and 60 years of age (inclusive) and older
  2. Assessing the vaccination rate among individuals with risk-based vaccination recommendation according to Standing Committee on Vaccination (Ständige Impfkommission) (STIKO) The study will target a disproportionate sample of the German population regarding age: 30% aged 18 years of age through and including 59 year of age and 70% aged 60 years of age (inclusive) and older. Within these age groups, the study targets a representative distribution regarding gender and region.

This study is conducted as an online survey that will either be self-completed by the respondents (CAWI) or completed via an interviewer for a subgroup of respondents aged 70+ (CATI). The survey is estimated to last 10 minutes and will comprise of closed-ended questions only (i.e., respondents will not have the possibility to add any free-text). The survey will be conducted in German.

The panelists will be divided into strata based on demographic variables like gender and region. Within each stratum, participants will be randomly selected to participate in the survey.

Enrollment

5,000 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Reside in Germany at the time of survey completion
  • Be at least 18 years old at the time of survey completion.
  • Agree with privacy policy and AE (Adverse Event) reporting requirements before proceeding with the survey.
  • Read and agree to the ICF (Informed Consent Form) by ticking a box before proceeding with the survey or telephone interview.

Exclusion criteria

  • Participation in the study (= completed the survey or telephone interview) in a previous wave of the current season.
  • Living in nursing home Note: The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.

Trial design

5,000 participants in 4 patient groups

Group 1: 18 Years of Age to 59 Years of age
Description:
Healthy diverse adults aged 18 years to 59 (inclusive) years of age
Group 2: 60 Years of Age and Older
Description:
Healthy diverse adults aged 60 years (inclusive) of age and older
Subgroup 1: Pregnant Women 18 Years of Age to 59 Years of Age
Description:
Pregnant woman aged 18 years to 59 (inclusive) years of age
Subgroup 2: Patients with Chronic Illness
Description:
Diverse patients with chronic illness

Trial contacts and locations

1

Loading...

Central trial contact

Trial Transparency email recommended (Toll free for US & Canada)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems